Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) EVP Monica Raines sold 437 shares of the stock in a transaction that occurred on Tuesday, February 24th. The stock was sold at an average price of $106.99, for a total value of $46,754.63. Following the transaction, the executive vice president directly owned 14,020 shares in the company, valued at approximately $1,499,999.80. This represents a 3.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Monica Raines also recently made the following trade(s):
- On Wednesday, February 25th, Monica Raines sold 219 shares of Addus HomeCare stock. The shares were sold at an average price of $105.36, for a total value of $23,073.84.
Addus HomeCare Stock Performance
Shares of ADUS stock traded down $0.51 on Friday, hitting $103.52. 14,471 shares of the stock traded hands, compared to its average volume of 233,037. The company’s fifty day moving average is $109.41 and its 200 day moving average is $113.01. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $124.43. The company has a market capitalization of $1.92 billion, a PE ratio of 19.85, a PEG ratio of 1.49 and a beta of 0.91. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.80 and a quick ratio of 1.66.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
Several research analysts have recently commented on ADUS shares. Truist Financial set a $135.00 price target on shares of Addus HomeCare and gave the company a “buy” rating in a report on Wednesday, January 7th. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Wednesday. Barclays dropped their price target on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday. Finally, Wall Street Zen raised Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $134.33.
Read Our Latest Analysis on Addus HomeCare
Trending Headlines about Addus HomeCare
Here are the key news stories impacting Addus HomeCare this week:
- Positive Sentiment: Stephens retained an “Overweight” rating on ADUS and set a $135 price target (trimmed from $140), keeping a constructive analyst opinion that supports medium-term upside. Read More.
- Positive Sentiment: Large institutional investors increased positions in recent quarters (Capital Research, Vanguard, Wasatch, State Street and others), signaling continued institutional confidence and buying power underneath the stock. Read More.
- Neutral Sentiment: Short-interest reporting is inconsistent across feeds (some entries show 0 shares, others show a material rise), creating data noise — investors should confirm with official FINRA/exchange data before sizing positions. Read More.
- Negative Sentiment: Insiders sold multiple tranches of stock on Feb. 24–25: CEO R. Dirk Allison sold several thousand shares (~7,300 across filings) and numerous EVPs also liquidated positions — concentrated insider selling often weighs on sentiment and can pressure the share price. Read More.
- Negative Sentiment: Reported short interest increased materially in February to roughly 1.15M shares (~6.5% of float, ~4.6 days to cover in mid-February) — a larger short book can amplify downside on negative headlines and increase volatility. Read More.
- Negative Sentiment: Media picked up a “pessimistic forecast” narrative tied to Stephens’ shorter-term expectations after the PT cut, which can reinforce selling pressure despite the retained Overweight rating. Read More.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Articles
- Five stocks we like better than Addus HomeCare
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
